Publication & Citation Trends
Publications
0 total
Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial.
Cited by 6
Semantic Scholar
Research Topics
Diabetes and associated disorders
(9)
Pancreatic function and diabetes
(8)
Scientific Computing and Data Management
(7)
Diabetes Management and Research
(6)
Machine Learning in Healthcare
(6)
Affiliations
University of Copenhagen
Novo Nordisk Foundation
Faculty of 1000 (United States)
M4 Engineering (United States)
Technical University of Denmark